We're committed to providing you with the very best cancer care, and your safety continues to be a top priority. With this in mind, we’ve put in place many new procedures, including a limited visitor policy. This is just one more way of ensuring your safety and that of our staff. Read more
Anti-PD-1 in Cancer Therapy: Understanding Response and Resistance
Tea will be served at 3:45 pm.
This program is open to the research community.
Date & Time(s)
Memorial Sloan Kettering Cancer Center
Zuckerman Research Center
417 East 68th Street
New York, NY 10065
Molecular Pharmacology and Chemical Biology Programs
Suzanne Topalian, MD
Professor of Surgery and Oncology
Director, Melanoma Program
Associate Director, Bloomberg-Kimmel Institute for Cancer Immunotherapy
Johns Hopkins University School of Medicine